ex.VAT:
VAT:
inc.VAT:

The 2025 edition of Paris Packaging Week!
Monday, April 6, 2020Covid

Covid-19: how the Chinese cosmetics industry will emerge from the crisis

Covid-19 : comment l’industrie cosmétique chinoise va sortir de la crise

As the coronavirus epidemic rages around the world, China is starting to come out of the water. It was the first country to be hit by Covid-19 and it took nearly two months of containment to contain the crisis. A necessary period, of course, but one that has had many consequences on the country’s economic landscape and its cosmetics industry.To take stock of the situation, Chemlinked organised a webinar. Summary report.

Reading time
~ 4 minutes

Life is slowly starting again in China.
Even if the population is still forced to go out wearing masks and is enjoined to scrupulously respect the gestures of the barriers, shops and businesses are gradually reopening.
According to Hedy He, Regulatory Analyst at ChemLinked, Covid-19 has had impacts on both aspects of Chinese cosmetic regulations, but also on the market.

Regulatory consequences

Hedy He counts three.

• A further delay in the entry into force of the CSAR (Cosmetics Supervision and Administration Regulations). “This new regulation was expected before the Chinese New Year. We will have to wait several weeks after the coronavirus crisis has been stopped in China before it is implemented,” explains the analyst.

• A mailing of paper copies of the filing documents rather than hand delivery.

• A delay in customs clearance of cosmetics. “The priority for customs officials is focused on medical equipment and anything else necessary to combat Covid-19. It is therefore to be expected that the control of cosmetics will take longer, as they are not considered essential,” she adds.

Consequences on the market

The supply chain is currently in backlog. Europe and Japan are the two main exporters of raw materials for …

This content is only available to subscribersPREMIUM, PRO, STARTUP, TPE and ABSTRACT

Already subscribed?Log in

Discover our subscriptions

CovidOther articles

78results